AbbVie Inc. is 192.1x more valuable than HUTCHMED (China) Ltd by market capitalization ($399.47 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HCM | ABBV |
|---|---|---|
| Market cap | $2.08 B | $399.47 B |
| US-listed rank | #2073 | #28 |
| Revenue (latest FY) | $548.51M | $61.16B |
| Net income (latest FY) | $456.91M | $4.23B |
| Net margin | 83.3% | 6.9% |
| P/E (trailing FY) | 4.6 | 94.5 |
| SEC filings | 589 | 1,008 |
AbbVie Inc. is 192.1x more valuable than HUTCHMED (China) Ltd by market capitalization ($399.47 B vs $2.08 B).
In their latest fiscal years, HUTCHMED (China) Ltd reported $548.51M in revenue while AbbVie Inc. reported $61.16B.
Full pages: HUTCHMED (China) Ltd and AbbVie Inc., or browse the full rankings.